{"id":"https://openalex.org/W4308385294","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.1131","title":"1131 GRWD5769: A first-in-class inhibitor of ERAP1, generating novel cancer antigens to drive de novo anti-tumor T cell responses","display_name":"1131 GRWD5769: A first-in-class inhibitor of ERAP1, generating novel cancer antigens to drive de novo anti-tumor T cell responses","publication_year":2022,"publication_date":"2022-11-01","ids":{"openalex":"https://openalex.org/W4308385294","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.1131"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2022-sitc2022.1131","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.1131","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.1131","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A1175.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A1175.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032039751","display_name":"Peter Ian Joyce","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Joyce","raw_affiliation_strings":["Grey Wolf Therapeutics, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grey Wolf Therapeutics, Oxford, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068519558","display_name":"Andrew J. Leishman","orcid":"https://orcid.org/0000-0003-4273-8188","observed_orcids":["https://orcid.org/0000-0003-4273-8188"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew Leishman","raw_affiliation_strings":["Grey Wolf Therapeutics, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grey Wolf Therapeutics, Oxford, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056261455","display_name":"Asolina Braun","orcid":"https://orcid.org/0000-0002-2646-5362","observed_orcids":["https://orcid.org/0000-0002-2646-5362"]},"institutions":[{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Asolina Braun","raw_affiliation_strings":["Monash University, Melbourne, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Monash University, Melbourne, Australia","institution_ids":["https://openalex.org/I56590836"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083126876","display_name":"Mitul Patel","orcid":"https://orcid.org/0009-0006-2051-6356","observed_orcids":["https://orcid.org/0009-0006-2051-6356"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mitul Patel","raw_affiliation_strings":["Grey Wolf Therapeutics, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grey Wolf Therapeutics, Oxford, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Michael Pinggera","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Pinggera","raw_affiliation_strings":["Grey Wolf Therapeutics, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grey Wolf Therapeutics, Oxford, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029747131","display_name":"Jessica Sette","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jessica Sette","raw_affiliation_strings":["Grey Wolf Therapeutics, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grey Wolf Therapeutics, Oxford, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039313243","display_name":"Kate Anderton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kate Anderton","raw_affiliation_strings":["Grey Wolf Therapeutics, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grey Wolf Therapeutics, Oxford, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Edd James","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I43439940","display_name":"University of Southampton","ror":"https://ror.org/01ryk1543","country_code":"GB","type":"education","lineage":["https://openalex.org/I43439940"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Edd James","raw_affiliation_strings":["University of Southampton, Southampton, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Southampton, Southampton, UK","institution_ids":["https://openalex.org/I43439940"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056479725","display_name":"Valeriya Shunina","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Valeriya Shunina","raw_affiliation_strings":["Grey Wolf Therapeutics, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grey Wolf Therapeutics, Oxford, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087347737","display_name":"Anthony Wayne Purcell","orcid":"https://orcid.org/0000-0003-0532-8331","observed_orcids":["https://orcid.org/0000-0003-0532-8331"]},"institutions":[{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Anthony Purcell","raw_affiliation_strings":["Monash University, Melbourne, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Monash University, Melbourne, Australia","institution_ids":["https://openalex.org/I56590836"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090536136","display_name":"Nicola Ternette","orcid":"https://orcid.org/0000-0002-9283-0743","observed_orcids":["https://orcid.org/0000-0002-9283-0743"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nicola Ternette","raw_affiliation_strings":["University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013159491","display_name":"Jason J. Shiers","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jason Shiers","raw_affiliation_strings":["Sygnature Discovery, Nottingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sygnature Discovery, Nottingham, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062898783","display_name":"Martin Quibell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin Quibell","raw_affiliation_strings":["Grey Wolf Therapeutics, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grey Wolf Therapeutics, Oxford, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015292930","display_name":"Wayne Paes","orcid":"https://orcid.org/0000-0002-0529-2765","observed_orcids":["https://orcid.org/0000-0002-0529-2765"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Wayne Paes","raw_affiliation_strings":["University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"last","author":{"id":null,"display_name":"Tom McCarthy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tom McCarthy","raw_affiliation_strings":["Grey Wolf Therapeutics, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grey Wolf Therapeutics, Oxford, UK","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A1175","last_page":"A1175"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8140000104904175,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8140000104904175,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.1808999925851822,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/erap1","display_name":"ERAP1","score":0.9660000205039978},{"id":"https://openalex.org/keywords/neoantigens","display_name":"neoantigens","score":0.8420000076293945},{"id":"https://openalex.org/keywords/t-cell-exhaustion","display_name":"T cell exhaustion","score":0.8360000252723694},{"id":"https://openalex.org/keywords/tcr-repertoire","display_name":"T cell receptor repertoire","score":0.800000011920929},{"id":"https://openalex.org/keywords/immunopeptidomics","display_name":"immunopeptidomics","score":0.9390000104904175},{"id":"https://openalex.org/keywords/tumor-infiltrating-t-cells","display_name":"tumor-infiltrating T cells","score":0.6690000295639038},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.6169999837875366}],"concepts":[{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.6334977149963379},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6018189191818237},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5565539598464966},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5340800285339355},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.51112300157547},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.45778289437294006},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4540879726409912},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4512665271759033},{"id":"https://openalex.org/C207936829","wikidata":"https://www.wikidata.org/wiki/Q423163","display_name":"Major histocompatibility complex","level":3,"score":0.43349942564964294},{"id":"https://openalex.org/C19317047","wikidata":"https://www.wikidata.org/wiki/Q412037","display_name":"T-cell receptor","level":4,"score":0.43087780475616455},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.41686737537384033},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.19077655673027039},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2022-sitc2022.1131","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.1131","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.1131","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A1175.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2022-sitc2022.1131","doi":"https://doi.org/10.1136/jitc-2022-sitc2022.1131","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2022-sitc2022.1131","pdf_url":"https://jitc.bmj.com/content/jitc/10/Suppl_2/A1175.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4308385294.pdf","grobid_xml":"https://content.openalex.org/works/W4308385294.grobid-xml"},"referenced_works_count":6,"referenced_works":["https://openalex.org/W2049553585","https://openalex.org/W2081921422","https://openalex.org/W2153228313","https://openalex.org/W2774712455","https://openalex.org/W2988620928","https://openalex.org/W3184584468"],"related_works":["https://openalex.org/W4362594837","https://openalex.org/W4282967611","https://openalex.org/W3211996152","https://openalex.org/W3100797614","https://openalex.org/W4388084724","https://openalex.org/W3178271449","https://openalex.org/W3083182260","https://openalex.org/W7019148924","https://openalex.org/W2163253520","https://openalex.org/W4415940404"],"abstract_inverted_index":{"Background":[0],"Immune":[1],"checkpoint":[2,439],"inhibitors":[3],"(ICI)":[4],"have":[5],"changed":[6],"the":[7,41,48,88,99,126,134,145,151,170,196,208,237,246,280,286,385,506],"cancer":[8,59,94,152,200,228,436,463,550],"treatment":[9],"paradigm,":[10],"yet":[11],"significant":[12],"unmet":[13],"need":[14],"remains.":[15],"Clinical":[16],"data":[17],"demonstrates":[18],"increased":[19],"antigen":[20,60,89,153,210],"presentation":[21],"diversity,":[22],"genomic":[23],"instability,":[24],"tumor":[25],"mutational":[26],"burden":[27],"and":[28,72,92,112,130,167,186,214,231,257,303,355,374,387,478],"HLA":[29,431,456],"diversity":[30],"are":[31,225],"all":[32],"factors":[33],"that":[34,205,301,379],"improve":[35],"clinical":[36,321],"response":[37,181,289,437],"to":[38,98,143,175,359,383,408,438],"ICI.1,2,3":[39],"Further,":[40,293],"effectiveness":[42],"of":[43,51,82,87,101,133,147,158,172,195,198,260,282,370,372,376,389,455,462,480,522,528],"ICI":[44],"is":[45,270],"limited":[46],"by":[47,57,222,307],"permanent":[49],"exhaustion":[50],"pre-existing":[52],"cytotoxic":[53],"T":[54,105,121,160,179,255,261,287,297,327,334,422,483],"cells,":[55,256],"caused":[56],"chronic":[58],"stimulation.4":[61],"Endoplasmic":[62],"reticulum":[63],"aminopeptidase":[64],"1":[65],"(ERAP1)":[66],"trims":[67],"peptides":[68],"loaded":[69],"into":[70,263],"classical":[71],"nonclassical":[73],"MHC":[74,501],"Class":[75],"I.5":[76],"In":[77,542],"cancer,":[78],"knockout":[79],"or":[80,218],"inhibition":[81,111,149,174,224,235,269,284,309],"ERAP1":[83,136,148,173,223,234,268,283,308,319],"changes":[84],"a":[85,114,177,337,350,549],"proportion":[86],"repertoire,":[90,154,239],"generating":[91],"up-regulating":[93],"antigens.6,7":[95],"This":[96],"leads":[97],"activation":[100],"de":[102],"novo":[103],"anti-tumor":[104,326],"cell":[106,122,161,180,190,201,229,288,298,312,328,335,413],"responses,":[107],"causing":[108],"tumour":[109,311],"growth":[110],"bypassing":[113],"key":[115,338],"resistance":[116,339],"mechanism":[117,340,373],"in":[118,182,245,341,368,391,393,411,485,505],"immuno-oncology":[119],"(IO),":[120],"exhaustion.":[123],"We":[124],"report":[125],"preclinical":[127],"development,":[128],"characterisation":[129],"mechanistic":[131],"analysis":[132,194],"first-in-class":[135],"inhibitor,":[137],"GRWD5769.":[138],"Methods":[139],"Immunopeptidomics":[140],"was":[141],"used":[142,382],"assess":[144],"impact":[146],"on":[150,285],"thus":[155],"determine":[156],"proof":[157,371,375],"mechanism.":[159],"receptor":[162],"(TCR)":[163],"repertoire":[164,211],"sequencing,":[165],"RNAseq":[166],"immunohistochemistry":[168],"established":[169],"ability":[171],"drive":[176,310],"differentiated":[178],"syngeneic":[183,264,273],"mouse":[184,265,277],"models":[185],"primary":[187],"human":[188,296],"immune":[189,242],"co-cultures.":[191],"Results":[192],"Extensive":[193,363],"immunopeptidomes":[197],"diverse":[199],"lines":[202],"robustly":[203],"showed":[204],"GRWD5769":[206,343,390],"modulates":[207],"cancer-related":[209],"across":[212,227,272],"genotypes":[213],"cancer-type":[215],"backgrounds.":[216,233],"Novel":[217],"upregulated":[219,304],"neoantigens":[220,305],"generated":[221,306],"conserved":[226],"types":[230],"genetic":[232],"diversified":[236],"TCR":[238],"up-regulated":[240],"prognostic":[241],"gene":[243],"markers":[244,249],"tumor,":[247],"including":[248,275],"for":[250,500],"recently":[251],"activated":[252],"(thus":[253],"non-exhausted)":[254],"drove":[258],"infiltration":[259],"cells":[262,484],"model":[266],"tumours.":[267],"efficacious":[271],"models,":[274],"different":[276],"strains.":[278],"Importantly,":[279],"effects":[281],"correlate":[290],"with":[291],"efficacy.":[292],"ex":[294],"vivo":[295,543],"co-cultures":[299],"demonstrate":[300],"novel":[302,325],"killing.":[313],"Conclusions":[314],"Grey":[315],"Wolf":[316],"Therapeutics\u2019":[317],"first-in-class,":[318],"inhibitor":[320],"candidate,":[322],"GRWD5769,":[323],"drives":[324],"responses":[329],"through":[330,526],"neoantigen":[331],"creation,":[332],"circumventing":[333],"exhaustion,":[336],"IO.":[342],"has":[344,349,366],"completed":[345],"GLP":[346],"toxicology":[347],"studies,":[348],"very":[351],"good":[352],"safety":[353],"profile":[354],"clear":[356],"path":[357],"forward":[358],"first":[360],"patient":[361],"dosed.":[362],"biomarker":[364],"development":[365,369],"resulted":[367],"principle":[377],"biomarkers":[378],"will":[380],"be":[381],"establish":[384],"activity":[386],"efficacy":[388,461],"patients":[392],"2023.":[394],"References":[395],"Rizvi":[396],"N,":[397,490,492],"Hellmann":[398],"MD,":[399],"Snyder":[400],"A,":[401],"et":[402,428,451,474,495,519,540],"al.":[403,429,475,496,520],"Mutational":[404],"landscape":[405],"determines":[406],"sensitivity":[407],"PD-1":[409],"blockade":[410,440],"non\u2013small":[412],"lung":[414],"cancer.":[415],"Science.":[416],"2015;348(6230):124\u2013128.":[417],"Chowell":[418,445],"D,":[419,446],"uc":[420],"G":[421],"Morris":[423],"LGT,2":[424],"3,":[425],"Grigg":[426],"CM":[427],"Patient":[430],"class":[432,457,502],"I":[433,458,503],"genotype":[434,459],"influences":[435],"immunotherapy.":[441,464],"Science":[442],"2018;359":[443],"(6375):582\u2013587":[444],"Chirag":[447],"Krishna,":[448],"Federica":[449],"Pierini":[450],"al":[452,541],"Evolutionary":[453],"divergence":[454],"impacts":[460],"Nature":[465,487,553],"Medicine":[466],"2019;25(11):1715\u20131720":[467],"Oliveira":[468],"G,":[469,518],"Stromhaug":[470],"K,":[471],"Klaeger":[472],"S,":[473],"Phenotype,":[476],"specificity":[477],"avidity":[479],"antitumour":[481],"CD8+":[482],"melanoma.":[486],"2021;596:119\u2013125":[488],"Shastri":[489],"Nagarajan":[491],"Lind":[493],"KC,":[494],"Monitoring":[497],"peptide":[498],"processing":[499],"molecules":[504],"endoplasmic":[507],"reticulum.":[508],"Curr":[509],"Opin":[510],"Immunol.":[511,532],"2014;26:123\u2013127.":[512],"James":[513],"E,":[514],"Bailey":[515],"I,":[516],"Sugiyarto":[517],"Induction":[521],"protective":[523],"antitumor":[524],"immunity":[525],"attenuation":[527],"ERAAP":[529],"function.":[530],"J":[531],"2013;190(11):5839\u20135846.":[533],"Manguso":[534],"RT,":[535],"Pope,":[536],"HW,":[537],"MD":[538],"Zimmer":[539],"CRISPR":[544],"screening":[545],"identifies":[546],"Ptpn2":[547],"as":[548],"immunotherapy":[551],"target.":[552],"2017;547(7664):413\u2013418":[554]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2022-11-11T00:00:00"}